Hogan Lovells advises Virbac on its agreement with ORIX Corporation for the acquisition of Sasaeah

Press releases | 12 March 2024

Tokyo, 12 March 2024 - Global law firm Hogan Lovells has advised Virbac on its definitive agreement with ORIX Corporation to acquire its Japanese animal health subsidiary, Sasaeah Holdings Co., Ltd. (Sasaeah), for an enterprise value of approximately €280 million. Sasaeah develops, manufactures, and markets veterinary products in Japan, including farm animal vaccines.

The transaction is strategically significant for Virbac and is an important step in the company’s plans for growth in Japan as well as across Asia.

The Hogan Lovells team advising Virbac was led by Corporate and Finance partners Jacky Scanlan-Dyas (Tokyo), Wataru Kamoto (Tokyo), and senior associate Jumpei Seto (Tokyo), with support from: partners Gaston P. Fernandez (Ho Chi Minh City) and Paul Leroy (Paris); counsel Viet Nguyen (Tokyo); senior associates Yasuyuki Shirabe (Tokyo), Long Huynh (Ho Chi Minh City), and Eleanor Cizeron (Paris); associates Reina Goto (Tokyo), Dang Nguyen (Ho Chi Minh City), and Ly Nguyen (Hanoi); paralegals Yuzumi Tsubaki (Tokyo) and Fumiko Ikeshiro (Tokyo); and trainee Linh Nguyen (Hanoi).

Jacky Scanlan-Dyas commented, “We are proud to be representing Virbac on this exciting and strategic acquisition, which demonstrates our team’s commitment to supporting clients at every stage of their most critical, Japan-linked M&A transactions, both inbound and outbound.”